BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20536070)

  • 21. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 22. Study: hospitalizations increase when only generic drugs are used for Medicare Advantage members.
    Capitation Manag Rep; 2005 Mar; 12(3):30-2. PubMed ID: 15889631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The new Medicare drug benefit: much ado about little?
    Pauly MV
    LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Medicare prescription drug benefit: focusing on coverage and cost.
    Cubanski J; Kline J
    Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing the intricate Web of prescription drugs.
    Eber BL
    Benefits Q; 2003; 19(1):45-50. PubMed ID: 12608118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The truth behind the prescription drug crisis.
    Start CA
    J Mich Dent Assoc; 2001 Jan; 83(1):54-6. PubMed ID: 11324265
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceuticals issue brief: pharmaceutical assistance for the elderly.
    Hackney C
    Issue Brief Health Policy Track Serv; 2000 Jul; ():1-10. PubMed ID: 11073431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients who pay out-of-pocket receive lower-cost drugs.
    Am J Health Syst Pharm; 1998 Aug; 55(15):1556-8. PubMed ID: 9706178
    [No Abstract]   [Full Text] [Related]  

  • 31. Perspectives. Drug formularies pose legal threat to providers.
    Moskowitz DB
    Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 34. The generic drug approval process.
    Rheinstein PH
    Am Fam Physician; 1993 Dec; 48(8):1357-60. PubMed ID: 8249762
    [No Abstract]   [Full Text] [Related]  

  • 35. Is There a Cure for High Drug Prices? A Special Investigation From Consumer Reports Best Buy Drugs.
    Consum Rep; 2016 Aug; 81(8):52-60. PubMed ID: 27459753
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription drug costs for Medicare beneficiaries: coverage and health status matter.
    Stuart B; Shea D; Briesacher B
    Issue Brief (Commonw Fund); 2000 Jan; (365):1-9. PubMed ID: 11584831
    [No Abstract]   [Full Text] [Related]  

  • 37. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 38. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
    Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
    Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicare prescription drug coverage (part D): challenges and opportunities.
    Witten B
    Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.